Showing 3851-3860 of 5660 results for "".
- Foamix, Ltd. Will Present Phase II Results for Topical Minocycline at Upcoming Conferencehttps://practicaldermatology.com/news/20140227-foamix_ltd_will_present_phase_2_results_for_topical_minocycline_at_upcoming_conference/2459328/Foamix will present the successful results from its Phase II clinical trials with topical minocycline for acne and impetigo at the 34th Annual Cowen & Company Health Care Conference. The pharmaceutical company, which focuses on the development of patented topical foams for de
- Eclipse Sun Launches New Line of Sun Protective Clothing for Babies and Kidshttps://practicaldermatology.com/news/20140220-eclipse_sun_launches_new_line_of_sun_protective_clothing_for_babies_and_kids/2459336/Eclipse Sun Products announced the introduction of its new line of sun protective clothing made especially for babies and kids. The
- Topix Pharmaceuticals Introduces Replenix Restorative Nighttime Bio-Therapyhttps://practicaldermatology.com/news/20140213-topix_pharmaceuticals_introduces_replenix_restorative_nighttime_bio-therapy/2459344/Topix Pharmaceuticals, Inc., launched its Replenix Restorative Nighttime Bio-Therapy cream, a moisture-boosting, rich night cream formulated to attract, hold, and distribute moisture through a system of ceramides, humectants, and em
- Curt Cole Wins "Best Presentation of the Day" and Lifetime Achievement Awards at Winter Clinical Dermatology Conferencehttps://practicaldermatology.com/news/20140128-curt_cole_wins_best_presentation_of_the_day_and_lifetime_achievement_awards_at_winter_clinical_dermatology_conference/2459357/"Beyond Broad Spectrum: Critical Concepts in a Post-Monograph World " - a podium presentation by photobiologist and industry veteran Curtis Cole, Ph.D, - was voted "Best Presentation of the Day," Tuesday, January 21 at the Winter Clinical Dermatology Conference. Given the broad scope of topics
- CSF 2013 Honors Top Resident Presentershttps://practicaldermatology.com/news/20131219-csf_2013_honors_top_resident_presenters/2459388/Nine residents have been recognized for their presentations at Cosmetic Surgery Forum 2013 held earlier this month. From a panel of residents who presented their research on a range of medical and cosmetic dermatology topics, the top
- Topical Nitric Oxide Shows Promisehttps://practicaldermatology.com/news/20131212-topical_nitric_oxide_shows_promise/2459395/Novan is kicking off a two-year program to support the pharmaceutical development of Nitric Oxide Advanced Healing (NOAH) technology, including formulation work, nonclinical toxicology, and proof of concept studies in models of deep partial-thickness and full-thickness thermal injuries. The
- Lithera Announces Appointment of Dr. Lincoln Krochmal as Chief Medical Officerhttps://practicaldermatology.com/news/20131121-lithera_announces_appointment_of_dr_lincoln_krochmal_as_chief_medical_officer/2459407/Lincoln Krochmal, MD was recently appointed as Chief Medical Officer of Lithera, Inc. According to the company, this appointment reflects the company's continued growth as it prepares to enter la
- Clear Clinic Acne Treatment Center Launches New Line, Online Componenthttps://practicaldermatology.com/news/20131119-clear_clinic_acne_treatment_center_launches_new_line_online_component/2459410/Clear Clinic Acne Treatment is launching a line of customized acne products along with an online program. Clear Clinic Online combines customized regimens from a new line of 19 acne products with guided care from a Personal Acne Coach, who will conduct consultations via video e-chat or telephone. Cl
- Valeant to Help Raise Awareness of Domestic Violencehttps://practicaldermatology.com/news/20131002-valeant_to_help_raise_awareness_of_domestic_violence/2459444/Valeant Pharmaceuticals International, Inc. (NYSE: VRX and TSX: VRX) is partnering with the National Coalition Against Domestic Violence (NCADV) to help raise awareness of domestic violence. As p
- Patient Savings Program Available for Mylan's Doxycycline Hyclatehttps://practicaldermatology.com/news/20130925-patient_savings_program_available_for_mylans_doxycycline_hyclate/2459450/Patients who are prescribed Mylan's bioequivalent alternative to Doryx (doxycycline hyclate delayed-release tablets) USP for severe acne may be eligible for an instant savings program. Patients who take their prescriptions to participating pharmacies will receive an automatic co-pay reduction at the